| HIV Infection |
1 |
1 |
| Pregnancy |
0 |
1 |
| Viral Load |
0 |
0.83 |
| Patient Safety |
0 |
0.68 |
| Hepatitis B Virus |
0 |
0.4 |
| Preconception |
0 |
0.3 |
| Postpartum |
0 |
0.24 |
| Antigens |
0 |
0.14 |
| HIV Transmission |
0 |
0.14 |
| Perinatal HIV Transmission |
0 |
0.12 |
| Adherence |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Immunization |
0 |
0.1 |
| Interprofessional Continuing Education |
0 |
0.1 |
| Opportunistic Infection |
0 |
0.1 |
| Prophylaxis |
0 |
0.1 |
| T-Lymphocyte |
0 |
0.1 |
| Vaginal Delivery |
0 |
0.1 |
| Biologic Therapy |
0 |
0.08 |
| Birth |
0 |
0.07 |
| Cancer |
0 |
0.07 |
| HIV-2 |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Lymphocytes |
0 |
0.07 |
| Maternal-Fetal Medicine |
0 |
0.07 |
| Newborn |
0 |
0.07 |
| Referral |
0 |
0.07 |
| Sexually Transmitted Infection |
0 |
0.07 |
| Sterilization, Birth Control |
0 |
0.07 |
| Vagina |
0 |
0.07 |
| HIV Diagnosis |
0 |
0.06 |
| Prenatal Screening and Diagnostics |
0 |
0.06 |
| Contraception |
0 |
0.05 |
| Protease Inhibitor |
0 |
0.05 |
| Adolescent Medicine |
0 |
0.04 |
| AIDS |
0 |
0.04 |
| Blood |
0 |
0.04 |
| Breast |
0 |
0.04 |
| Cervical Cancer |
0 |
0.04 |
| Cesarean Delivery |
0 |
0.04 |
| Chemoprophylaxis |
0 |
0.04 |
| Child |
0 |
0.04 |
| Cytology |
0 |
0.04 |
| Disaster Medicine |
0 |
0.04 |
| Fertility |
0 |
0.04 |
| Food and Drug Administration (FDA) |
0 |
0.04 |
| Gestational Diabetes Mellitus |
0 |
0.04 |
| HIV Prevention |
0 |
0.04 |
| HIV Testing |
0 |
0.04 |
| Human Papillomavirus |
0 |
0.04 |
| Immunodeficiency |
0 |
0.04 |
| Insurance |
0 |
0.04 |
| Intravenous |
0 |
0.04 |
| Multidisciplinary Team |
0 |
0.04 |
| Papillomavirus |
0 |
0.04 |
| Personal Protective Equipment |
0 |
0.04 |
| Preventive Screening |
0 |
0.04 |
| Proteases |
0 |
0.04 |
| Routine Prenatal Care |
0 |
0.04 |
| Scalp |
0 |
0.04 |
| Tolerance |
0 |
0.04 |
| Wound Management |
0 |
0.03 |
| Antibiotics |
0 |
0.01 |
| Revenue and Practice Management |
0 |
0.01 |